Insider Trading & Executive Data
Start Free Trial
33 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
Middlesex Water Company (MSEX) is a regulated water and wastewater utility holding company serving roughly 128,000 customers primarily in New Jersey and Delaware through subsidiaries including Middlesex, Tidewater, Pinelands and others. The company’s 2024 consolidated revenues were $191.9 million with net income of $44.4 million; the Middlesex system accounts for about 67% of revenue and Tidewater about 24%. Middlesex’s business model depends on state public utility commission approvals (NJBPU, DEPSC) for rates and recovery mechanisms, is managing a large multi‑year capital program (~$93M in 2025; ~$387M over 2025–2027), and faces material regulatory and compliance drivers including USEPA PFAS rules and lead service line requirements. Operational risks include timing of rate relief, seasonal demand swings, reliance on purchase contracts (notably a long-term NJ Water Supply Authority contract) and elevated O&M and energy costs.
Compensation at a regulated water utility like Middlesex is likely tied to regulatory outcomes, capital project execution, operational reliability and financial stability rather than growth metrics alone. Given the filing emphasis on rate case results, DSIC and surcharge recoveries (e.g., $15.4M Middlesex base rate increase in 2024, DSIC authorization, lead LSL surcharges), short‑term incentives are likely to include targets linked to successful rate relief, meeting approved capital spend and cost control versus authorized budgets. Long‑term pay probably emphasizes total shareholder return and equity awards, but pension/OPEB and retirement benefits are material here (critical accounting policies listed), so fixed compensation and legacy benefit funding also influence pay. Management commentary on succession, safety and treatment project delivery (PFAS investments ~ $105M at CJO plant) suggests operational KPIs—safety, main‑break frequency, treatment compliance and timely project milestones—will be prominent in incentive scorecards.
Insider trading activity at Middlesex should be viewed through the lens of predictable regulatory cadence and discrete material events: base rate filings/approvals, DSIC determinations, PFAS treatment cost milestones, the 3M settlement reclassification and any equity issuances (ATM program and potential authorized equity under the Investment Plan). Executives with material nonpublic knowledge of pending rate cases, acquisition timing (e.g., Ocean View), or large capital funding decisions will typically be subject to blackout windows and pre‑clearance; 10b5‑1 plans or scheduled sales are common in utilities to avoid signaling. Because regulated utilities have steadier cash flows, insider selling is often diversification rather than a negative signal, but sudden trades ahead of rate denials, cost overruns on PFAS projects, or unexpected regulatory actions can be informative. Monitor Form 4 filings relative to rate case dates, PFAS regulatory milestones, ATM issuances and quarterly results to distinguish routine diversification from potentially informative insider moves.